Analyst Activity – Credit Suisse Group Reiterates Hold on Ascendis Pharma A/S (NASDAQ:ASND)

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Story continues below

Today, Credit Suisse Group reiterated its Hold rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $50.00.

Some recent analyst ratings include

  • 3/20/2018-Credit Suisse Group Reiterated Rating of Hold.
  • 2/26/2018-Wedbush Reiterated Rating of Outperform.
  • 1/19/2018-HC Wainwright Reiterated Rating of Buy.
  • 1/17/2018-JPMorgan Chase & Co. Reiterated Rating of Buy.
  • 9/22/2017-Wells Fargo Reiterated Rating of Buy.
  • 9/1/2017-Leerink Swann Reiterated Rating of Hold.

    Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
    Shares of Ascendis Pharma A/S closed the previous trading session at 64.90 up +1.89 3.01% with 13662 shares trading hands.

    An ad to help with our costs